GlassScriptPhysician profile
Phillip Brunson
NPI 1265435507
$214,202.36
in general payments reported to CMS, 2019-2025
33 companies · $69K in 2025
The $69K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $9,840 · 2021: $13K · 2022: $44K · 2023: $15K · 2024: $34K · 2025: $69K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $82K · Travel and Lodging: $13K · Food and Beverage: $11K · Consulting Fee: $9,838 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,700 · Education: $35.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $81,662.77 |
| Travel and Lodging | $12,906.76 |
| Food and Beverage | $11,354.82 |
| Consulting Fee | $9,837.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,700.00 |
| Education | $35.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $89,545.83 | 2024-2025 | Xdemvy |
| Allergan, INC. | $53,928.52 | 2019-2022 | |
| Abbvie INC. | $29,389.21 | 2022-2025 | Vuity, Lumigan, Alphagan P |
| Novartis Pharmaceuticals Corporation | $13,765.99 | 2019-2023 | |
| Alcon Vision LLC | $6,513.93 | 2019-2025 | Wavelight Ex500 Excimer Laser, Wavelight Refractive Suite, Precision 1 |
| Sun Pharmaceutical Industries INC. | $5,651.88 | 2019-2025 | Cequa |
| Eyevance Pharmaceuticals LLC | $4,532.34 | 2019-2021 | |
| Alcon Research LLC | $3,750.00 | 2025 | Wavelight Ex500 Excimer Laser, Wavelight |
| Shire North American Group INC | $2,930.41 | 2019 | |
| Oyster Point Pharma, INC. | $936.38 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Carl Zeiss Meditec USA, INC. | $388.38 | 2021-2025 | Clarus, Cirrus Hd-Oct |
| Bausch & Lomb Americas INC. | $379.54 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Biotissue Holdings INC. | $367.27 | 2019-2024 | |
| Dompe US, INC. | $271.14 | 2019-2025 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $264.99 | 2019-2023 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $232.62 | 2022 | |
| Amgen INC. | $211.97 | 2024-2025 | Tepezza |
| Johnson & Johnson Vision Care, INC. | $182.39 | 2019-2025 | |
| Harrow Eye, LLC | $169.30 | 2024-2025 | Vevye |
| New World Medical,INC. | $165.17 | 2025 | Streamline, Via360, Kahook Dual Blade |
| Kala Pharmaceuticals, INC. | $140.67 | 2020-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $113.64 | 2019-2021 | |
| Astellas Pharma US INC | $58.07 | 2024 | Izervay |
| Sight Sciences, INC. | $57.60 | 2019-2025 | Tearcare System |
| Carl Zeiss Meditec, INC. | $55.56 | 2019 | |
| Rayner Intraocular Lenses Limited | $44.68 | 2025 | Rayone Aspheric, Rayone Emv, Rayner Cataract Set 1 |
| Maculogix, INC. | $32.98 | 2019 | |
| Coopervision INC. | $26.11 | 2022 | |
| Aerie Pharmaceuticals, INC. | $22.92 | 2019 | |
| Mallinckrodt Enterprises LLC | $22.30 | 2019 | |
| Topcon Healthcare Solutions, INC. | $21.43 | 2019 | |
| Derma Sciences, INC. | $17.30 | 2019 | |
| Quidel Corporation | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Brunson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.